We've found
184,457
clinical trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Supra-ventricular Tachyarrhythmias Clinical Trial
Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias
Status: Enrolling,
Phase
II
Updated: 9/21/2015
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics
Status: Enrolling,
Phase
I
Updated: 10/9/2014
Click here to add this to my saved trials
Patients Transplanted With NiCord/CordIn Clinical Trial
Long Term Follow Up Protocol for NiCord®/CordIn™ Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Muscle Tear Clinical Trial
Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears
Status: Enrolling,
Phase
I, II
Updated: 1/23/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Focus: Long-term Retention of Gadolinium Contrast Agent Received Independent of Indication Clinical Trial
Long-Term Retention of Gadolinium in Bone
Status: Enrolling,
Phase
IV
Updated: 4/27/2018
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
We've found
184,457
clinical trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Supra-ventricular Tachyarrhythmias Clinical Trial
Updated: 9/21/2015
Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias
Status: Enrolling,
Phase
II
Updated: 9/21/2015
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Updated: 12/31/1969
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 8/16/2017
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 8/16/2017
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 8/16/2017
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 8/16/2017
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 8/16/2017
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)
Status: Enrolling,
Phase
I
Updated: 8/16/2017
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/4/2015
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling,
Phase
III
Updated: 2/4/2015
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 10/9/2014
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics
Status: Enrolling,
Phase
I
Updated: 10/9/2014
Click here to add this to my saved trials
Patients Transplanted With NiCord/CordIn Clinical Trial
Updated: 12/31/1969
Long Term Follow Up Protocol for NiCord®/CordIn™ Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Muscle Tear Clinical Trial
Updated: 1/23/2014
Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears
Status: Enrolling,
Phase
I, II
Updated: 1/23/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Focus: Long-term Retention of Gadolinium Contrast Agent Received Independent of Indication Clinical Trial
Updated: 4/27/2018
Long-Term Retention of Gadolinium in Bone
Status: Enrolling,
Phase
IV
Updated: 4/27/2018
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
Updated: 4/18/2014
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
Updated: 4/18/2014
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials